Armata Pharmaceuticals (ARMP) Financials

$4.40

$-3.96 (-47.37%)

As on 15-Sep-2026 16:18EDT

Market cap

$200 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

--

P/B Ratio

2.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	5.54	4.90	5.17	4.53	5.51	4.47
Cost of Revenue	1.84	1.53	34.43	0.97	35.02	20.02
Gross Profit	3.71	3.37	-29.25	3.56	-29.51	-15.54
Operating Expenses	42.95	34.60	13.18	44.45	7.44	8.28
Operating Profit (EBIT)	-40.70	-31.22	-42.44	-40.89	-36.95	-23.82
Other Income	--	--	--	--	0.03	0.67
Profit before Tax	-192.18	-173.80	-18.92	-69.05	-36.92	-23.16
Provision for Tax	--	--	--	--	-0.03	0.06
Profit after Tax (Net Income)	-192.18	-173.80	-18.92	-69.05	-36.92	-23.16
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-36.92	-23.16

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-231.17	-218.60	-48.02	-32.07	36.08	25.40
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	70.92	286.53	86.21	113.97	46.92	39.56
Current Liabilities	250.20	8.95	48.25	16.46	24.87	4.81
Total Liabilities	340.15	76.88	86.44	98.36	107.88	69.77

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	62.79	66.21	75.13	79.21	80.83	54.77
Current Assets	27.16	10.67	11.31	19.15	27.05	15.00
Total Assets	117.11	76.88	86.44	98.36	107.88	69.77
Total Debt*	313.95	288.02	126.52	120.37	48.82	37.99
Net Current Assets	--	1.72	-36.94	2.69	2.17	10.18

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-25.76	-37.55	-47.42	-32.48	-23.58
Cash Flow from Investing Activities	--	-0.54	-1.88	-8.13	-2.21	-1.30
Cash from Financing Activities	--	25.61	34.96	53.99	44.02	25.52
Net Cash Inflow / Outflow	--	--	--	--	9.32	0.64

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-6.12	-4.78	-0.32	-1.91	-1.02	-0.88
Cash EPS ($)	--	-4.74	-0.30	-1.89	-1.00	-0.84
Adjusted Book Value ($)	--	--	--	--	1.00	0.97
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.71	-0.64	-1.31	-0.90	-0.90
Free Cash Flow per Share ($)	--	-0.72	-0.67	-1.54	-0.96	-0.95

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-234.99	-22.68	-79.73	-49.79	-48.55
ROE (%)	--	130.37	47.24	-3,439.35	-120.10	-104.65
ROA (%)	-120.87	-212.83	-20.47	-66.96	-41.56	-42.38
EBIT Margin (%)	-3,081.45	-3,205.73	-157.98	-1,466.53	-669.72	-516.12
Net Margin (%)	-3,467.04	-3,544.03	-365.60	-1,524.51	-666.73	-450.40
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-19.29	-0.05	0.14	-0.18	0.23	4.44
EBIT Growth (%)	-1,312.31	-1,823.28	87.69	-80.06	-59.75	-7.14
Net Profit Growth (%)	-647.57	-818.79	72.60	-87.03	-59.43	-4.39
EPS Growth (%)	-728.90	-13.94	0.83	-0.87	-0.16	0.27
Book Value Growth (%)	-94.04	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.31	-5.78	-1.69	-1.21	-6.23
Price / Book Value	2.11	-1.04	-2.28	-3.65	1.24	5.68
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	14.44	-3.26	-33.07	-3.42	-2.19	-7.84
Close Price ($)	--	6.28	1.85	3.24	1.24	5.48
High Price ($)	--	16.34	4.48	5.26	6.46	10.48
Low Price ($)	--	0.90	1.80	0.99	0.83	2.82
Market Cap ($ Cr)	200.04	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-1.32	-2.63	-3.75	1.35	1.50
Short term debt to equity ratio	-1.06	-0.02	-0.90	-0.30	0.47	0.06
Current Ratio	0.11	1.19	0.23	1.16	1.09	3.11
Quick Ratio	0.11	--	--	--	--	3.74
Interest Coverage	-7.99	-9.48	-0.76	-25.29	-1,272.00	-360.80

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	45.68	9.62	14.38	74.25	154.88	66.81
Asset Turnover	0.03	0.06	0.06	0.04	0.06	0.08
Receivable days	--	45.28	144.96	479.61	381.96	144.91
Inventory Days	--	--	--	--	-31.18	-32.39
Payable days	--	201.23	12.47	613.07	14.69	19.11
Cash Conversion Cycle	--	--	--	--	336.10	93.41

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.